(Q50904360)
Statements
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML. (English)
1 reference
1 reference
Julie A McEarchern
1 reference
May S Kung Sutherland
1 reference
Scott C Jeffrey
1 reference
Patrick J Burke
1 reference
Changpu Yu
1 reference
Heather Kostner
1 reference
Ivan Stone
1 reference
Maureen C Ryan
1 reference
Django Sussman
1 reference
Robert P Lyon
1 reference
Weiping Zeng
1 reference
Kimberly H Harrington
1 reference
Kerry Klussman
1 reference
Lori Westendorf
1 reference
David Meyer
1 reference
Irwin D Bernstein
1 reference
Peter D Senter
1 reference
Dennis R Benjamin
1 reference
Jonathan G Drachman
1 reference
14 June 2013
1 reference
1 reference
122
1 reference
8
1 reference
1455-1463
1 reference